The Center for Health Research, Kaiser Permanente Northwest, Portland, Oregon, USA.
Department of Research and Evaluation, Kaiser Permanente Southern California, Portland, Oregon, USA.
J Palliat Med. 2022 Apr;25(4):620-627. doi: 10.1089/jpm.2021.0164. Epub 2021 Nov 3.
The research enterprise has embraced patient centeredness in embedded efficient pragmatic trials, but limited data exist on using patient-reported outcomes (PROs) collected as part of usual clinical care for research. We sought to assess the performance of different assessment methods for obtaining PROs in a pragmatic cluster randomized trial (HomePal study) designed to compare two models of home-based palliative care (HBPC). Descriptive analytics, comparative trends, and psychometric performance of PROs collected in the HomePal study; measures included Edmonton Symptom Assessment System (ESAS), PROMIS-10, and others administered at baseline, 1, and 6 months. HomePal was conducted in the Southern California and Northwest Kaiser Permanente regions in the United States; subjects were patients receiving HBPC and their caregivers. We specifically compared ESAS obtained by research staff with those obtained by clinical HBPC nurses at the time of HBPC enrollment. We also compared ESAS completed by patients versus if done or assisted by a caregiver (proxy). We enrolled 3533 patients and had 2205 ESAS measurements that met the criteria for analysis at baseline and 1447 at the one-month follow-up assessment. Research staff-obtained ESAS at admission to HBPC was higher overall (indicating more symptoms) than the clinically collected measure whether symptoms were reported by patients (31.7 ± 15.4 vs. 26.0 ± 13.4) or by proxies (36.9 ± 15.6 vs. 26.5 ± 13.5). These differences persisted with follow-up ESAS measures. We identified significant variability in PRO responses between different surveyors and whether proxy interaction was needed suggesting complex issues around PRO measure performance for pragmatic embedded trials. ClinicalTrials.gov Identifier: NCT03694431.
研究机构已经在嵌入式高效实用试验中接受了以患者为中心的理念,但关于使用作为常规临床护理一部分收集的患者报告结果 (PRO) 进行研究的数据有限。我们旨在评估在一项旨在比较两种家庭姑息治疗 (HBPC) 模式的实用集群随机试验 (HomePal 研究) 中获得 PRO 的不同评估方法的性能。描述性分析、比较趋势和 HomePal 研究中收集的 PRO 的心理测量性能;测量包括 Edmonton 症状评估系统 (ESAS)、PROMIS-10 以及在基线、1 个月和 6 个月时进行的其他测量。HomePal 在美国南加州和西北 Kaiser Permanente 地区进行;研究对象为接受 HBPC 的患者及其护理人员。我们特别比较了研究人员获得的 ESAS 与 HBPC 登记时临床 HBPC 护士获得的 ESAS。我们还比较了患者自行完成的 ESAS 与由护理人员 (代理人) 完成或协助完成的 ESAS。我们共纳入了 3533 名患者,有 2205 份 ESAS 测量值符合基线和 1447 份一个月随访评估的分析标准。HBPC 入院时,研究人员获得的 ESAS 总体上更高(表明症状更多),无论是由患者(31.7±15.4 比 26.0±13.4)还是代理人(36.9±15.6 比 26.5±13.5)报告症状。这些差异在后续的 ESAS 测量中仍然存在。我们发现不同调查员之间的 PRO 反应存在显著差异,以及是否需要代理交互,这表明在实用嵌入式试验中,PRO 测量性能存在复杂问题。ClinicalTrials.gov 标识符:NCT03694431。